Clinical Trial Update: Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED) [Phase 4]

View source ↗

Summary

This is a termination update for a Phase 4 trial evaluating Nasonex (mometasone furoate) for sleep disturbances related to perennial allergic rhinitis. Results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Nasonex (mometasone furoate)

Snippet

Sponsor: Schering-Plough | Conditions: Perennial Allergic Rhinitis | Phase 4 | Status: TERMINATED | Results posted: 2009-01-06